October 26, 2007 (FinancialWire) The U.S. Food and Drug Administration is investigating complaints about a generic version of the antidepressant drug Wellbutrin XL after users reported having headaches, anxiety and other ailments.
October 26, 2007 (FinancialWire) The U.S. Food and Drug Administration is investigating complaints about a generic version of the antidepressant drug Wellbutrin XL after users reported having headaches, anxiety and other ailments.
